STOCK TITAN

Rapid Micro Biosystems (RPID) director exercises options for 3,508 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rapid Micro Biosystems, Inc. director Richard S. Kollender reported exercising stock options covering a total of 3,508 shares of Class A Common Stock on 2026-07-24. The options, described as fully vested and exercisable, were exercised at an exercise price of $0.7500 per share in two tranches of 1,681 and 1,827 underlying shares.

Positive

  • None.

Negative

  • None.
Insider Kollender Richard S
Role Director
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1 1,681 $0.00 $0.00
Exercise Stock Option (Right to Buy) F1 1,827 $0.00 $0.00
Exercise Class A Common Stock 1,681 $0.75 $1K
Exercise Class A Common Stock 1,827 $0.75 $1K
Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Class A Common Stock — 133,826 shares (Direct)
Footnotes (1)
  1. F1. The option is fully vested and exercisable.
Options exercised 3508 shares Total underlying Class A Common Stock from options exercised on 2026-07-24
First option tranche 1681 shares Underlying Class A Common Stock from one Stock Option (Right to Buy) exercise
Second option tranche 1827 shares Underlying Class A Common Stock from the second Stock Option (Right to Buy) exercise
Exercise price $0.7500 per share Conversion or exercise price for the Stock Option (Right to Buy) positions
Option expiration date 2026-08-11 Expiration date for the exercised stock options
Stock Option (Right to Buy) financial
"Transaction security title is Stock Option (Right to Buy)"
Class A Common Stock financial
"Underlying security title is Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Exercise or conversion of derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security"
fully vested and exercisable financial
"A footnote states the option is fully vested and exercisable"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Richard S. Kollender report for RPID?

Richard S. Kollender, a director of Rapid Micro Biosystems (RPID), reported exercising stock options on 2026-07-24. The transactions converted options into 3,508 shares of Class A Common Stock through two separate exercises disclosed in the Form 4 data.

How many shares were acquired and at what price in the RPID Form 4?

Kollender acquired 3,508 shares of Rapid Micro Biosystems Class A Common Stock by exercising options at an exercise price of $0.7500 per share. The exercises occurred in two tranches of 1,681 and 1,827 shares on the same date.

What type of securities were involved in Richard Kollender’s RPID insider transaction?

The transactions involved Stock Option (Right to Buy) derivative securities that converted into Class A Common Stock. Two option positions were exercised, each delivering the same number of underlying shares as the options exercised, at a stated exercise price of $0.7500 per share.

Were the options exercised by the RPID director fully vested?

Yes. A footnote states that the option is fully vested and exercisable. This note applies to the reported option positions that were exercised, indicating there were no remaining vesting conditions at the time of the 2026-07-24 exercises.

When did the Rapid Micro Biosystems options exercised by Kollender expire?

For the exercised options, the Form 4 data shows an expiration date of 2026-08-11. These options were exercised on 2026-07-24, ahead of that expiration date, converting them into shares of Class A Common Stock at the stated exercise price.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kollender Richard S

(Last)(First)(Middle)
C/O RAPID MICRO BIOSYSTEMS, INC.
25 HARTWELL AVENUE

(Street)
LEXINGTON MASSACHUSETTS 02421

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RAPID MICRO BIOSYSTEMS, INC. [ RPID ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/24/2026M1,681A$0.75131,999D
Class A Common Stock07/24/2026M1,827A$0.75133,826D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.7507/24/2026M1,681 (1)08/11/2026Class A Common Stock1,681$00D
Stock Option (Right to Buy)$0.7507/24/2026M1,827 (1)08/11/2026Class A Common Stock1,827$00D
Explanation of Responses:
1. The option is fully vested and exercisable.
Remarks:
/s/ Sean M. Wirtjes, Attorney-in-Fact for Richard S. Kollender07/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)